Cargando…
Combined oncolytic virotherapy gold nanoparticles as synergistic immunotherapy agent in breast cancer control
Combining viruses and nanoparticles may be a way to successfully treat cancer and minimize adverse effects. The current work aimed to evaluate the efficacy of a specific combination of gold nanoparticles (GNPs) and Newcastle disease virus (NDV) to enhance the antitumor effect of breast cancer in bot...
Autores principales: | Jabir, Majid S., Al-Shammari, Ahmed M., Ali, Zainab O., Albukhaty, Salim, Sulaiman, Ghassan M., Jawad, Sabrean F., Hamzah, Sawsan S., Syed, Asad, Elgorban, Abdallah M., Eswaramoorthy, Rajalakshmanan, Zaghloul, Nouf S. S., Al-Dulimi, Ali G., Najm, Mazin A. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558528/ https://www.ncbi.nlm.nih.gov/pubmed/37803068 http://dx.doi.org/10.1038/s41598-023-42299-4 |
Ejemplares similares
-
Editorial: Oncolytic virotherapy
por: Al-Shammari, Ahmed Majeed, et al.
Publicado: (2023) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012) -
Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022) -
Oncolytic Virotherapy with Myxoma Virus
por: Rahman, Masmudur M., et al.
Publicado: (2020) -
Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)